The Amgen Scholars Spring 2017 Travel Award Opens


The Amgen Scholars Global Program Office is now accepting applications for Spring 2017 U.S. Alumni Travel Awards. The deadline for application submission is April 21, 2017.

Access the application and recommender form.

About the award

Meet Amgen Scholars Alumni Arvind Kumar

Although I had research experience in statistics and epidemiology, the Amgen Scholars Program gave me my first hands-on bench experience.

Roslyn, New York

Host University: University of Tokyo

Home University: Duke University

Amgen Scholar Year: 2016

Major: Math and Chemistry

Expected Graduation: 2017

Journey to Science

How did you become interested in science?

How Bloomberg Integrated Learning-to-Rank into Apache Solr


The latest milestone in open source development at Bloomberg is the incorporation of the Learning-to-Rank (LTR) plug-in into Apache Solr 6.4.0, which shipped this week.

Study Finds Executives Meet Key Business Goals Through Corporate Citizenship

Boston College Center for Corporate Citizenship Report Illustrates the Role of Corporate Citizenship in Business Success
Press Release

CHESTNUT HILL, Mass., Jaunary 26, 2017 /3BL Media/—Boston College Center for Corporate Citizenship is pleased to release the 2017 State of Corporate Citizenship, a unique research report that examines how executives view corporate citizenship in both business and global contexts, and identifies the topics and issues they find most important.

Meet Amgen Scholars Alumni Assama Ketegou

"I felt a sense of community among my peers in the Amgen Scholars Program. Everyone was in the same boat, trying to figure out what they wanted to do for careers."

Host University: Washington University in St. Louis

Home University: New York University

Amgen Scholar Year: 2016

Major: Pre-medicine

Expected Graduation:2017

Journey to Science

How did you become interested in science?

Gilead Awards More Than $22 Million in Grants to Support HIV Cure Research

Funds to support results-driven research and community projects engaged in HIV cure activities
Press Release

FOSTER CITY, Calif., January 11, 2017 /3BL Media/ -- Gilead Sciences, Inc.(Nasdaq:GILD) today announced the recipients of its HIV cure grants program, a fund totaling more than $22 million, which will support 12 new HIV cure research projects.

Sanofi Rises 2 Positions in the 2016 Access to Medicine Index


In 2016, Sanofi has risen 2 positions in the Access To Medicine (ATM) Index, from 8th to 6th rank. The ATM Index analyses the top 20 research-based pharmaceutical companies on how they make medicines, vaccines and diagnostics more accessible in low- and middle-income countries.

Sanofi’s performance is well recognized this year in the two main areas, which represent 45% of the overall score and are major enablers of access:

Research & Development:


Subscribe to Research